EPISODE · Apr 17, 2026 · 1 MIN
IOA-244(p110δ PI3K) Stops Breast Tumor Progression Mono/Combo Tx
from TheBrief.Health · host TheBrief.Health
IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and biomarker-guided combination strategies.
What this episode covers
IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and biomarker-guided combination strategies.
NOW PLAYING
IOA-244(p110δ PI3K) Stops Breast Tumor Progression Mono/Combo Tx
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m